[HTML] mdpi.com

[HTML][HTML] Biomarkers for malignant pleural mesothelioma—A novel view on inflammation

M Vogl, A Rosenmayr, T Bohanes, A Scheed… - Cancers, 2021 - mdpi.com
Simple Summary In view of the recent advances in immunoncology, we want to reevaluate
and summarize the role of the immune system in malignant pleural mesothelioma (MPM) …
被引用次数：26 相关文章

Biomarkers for Malignant Pleural Mesothelioma-A Novel View on Inflammation.

M Vogl, A Rosenmayr, T Bohanes, A Scheed… - Cancers, 2021 - europepmc.org
Malignant pleural mesothelioma (MPM) is an aggressive disease with limited treatment
response and devastating prognosis. Exposure to asbestos and chronic inflammation are …
[HTML] nih.gov

[HTML][HTML] Biomarkers for Malignant Pleural Mesothelioma—A Novel View on Inflammation

M Vogl, A Rosenmayr, T Bohanes, A Scheed… - Cancers, 2021 - ncbi.nlm.nih.gov
Malignant pleural mesothelioma (MPM) is an aggressive disease with limited treatment
response and devastating prognosis. Exposure to asbestos and chronic inflammation are …

Biomarkers for Malignant Pleural Mesothelioma—A Novel View on Inflammation.

M Vogl, A Rosenmayr, T Bohanes, A Scheed… - …, 2021 - search.ebscohost.com
Abstract Simple Summary: In view of the recent advances in immunoncology, we want to
reevaluate and summarize the role of the immune system in malignant pleural …

Biomarkers for Malignant Pleural Mesothelioma-A Novel View on Inflammation

M Vogl, A Rosenmayr, T Bohanes, A Scheed… - …, 2021 - pubmed.ncbi.nlm.nih.gov
Malignant pleural mesothelioma (MPM) is an aggressive disease with limited treatment
response and devastating prognosis. Exposure to asbestos and chronic inflammation are …

Biomarkers for Malignant Pleural Mesothelioma-A Novel View on Inflammation

M Vogl, A Rosenmayr, T Bohanes, A Scheed… - Cancers, 2021 - hero.epa.gov
Malignant pleural mesothelioma (MPM) is an aggressive disease with limited treatment
response and devastating prognosis. Exposure to asbestos and chronic inflammation are …